This inventor holds 1 USPTO granted patent. Top assignee: Pure Tech Lyt 100, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yanqiong Zhang: Innovator in Pulmonary Fibrosis Treatment
Introduction
Yanqiong Zhang is a prominent inventor based in Westborough, MA (US). She has made significant contributions to the field of medicine, particularly in the treatment of idiopathic pulmonary fibrosis (IPF). Her innovative approach has the potential to improve the lives of many patients suffering from this debilitating condition.
Latest Patents
Yanqiong Zhang holds a patent for "Methods of treating idiopathic pulmonary fibrosis with deupirfenidone." This patent discloses a method of treating IPF by administering deuterium-enriched pirfenidone, known as LYT-100, at a total daily dose ranging from about 1650 mg to about 2500 mg. This advancement represents a significant step forward in the management of IPF.
Career Highlights
Zhang is associated with PureTech Lyt 100, Inc., where she continues to develop and refine her innovative treatments. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Some of her notable coworkers include Michael C Chen and Eric Elenko, who contribute to the collaborative efforts at PureTech Lyt 100, Inc. Their combined expertise fosters an environment of innovation and progress in the field.
Conclusion
Yanqiong Zhang's contributions to the treatment of idiopathic pulmonary fibrosis exemplify the impact of dedicated inventors in the medical field. Her work not only highlights her innovative spirit but also underscores the importance of collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile